Ginkgo Bioworks Holdings (DNA) Receivables - Net (2021 - 2026)

Ginkgo Bioworks Holdings' Receivables - Net history runs 6 years deep, the most recent figure standing at $454000.0 for Q1 2026.

• Quarterly Receivables - Net fell 98.27% year-over-year to $454000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $454000.0 (down 98.27% YoY) and the FY2025 annual result came in at $24.0 million, up 4000.0% from the prior year.
• Receivables - Net was $454000.0 for Q1 2026 at Ginkgo Bioworks Holdings, down from $24.0 million in the prior quarter.
• Across five years, Receivables - Net topped out at $171.6 million in Q2 2022 and bottomed at $302000.0 in Q2 2024.
• A 5-year average of $43.9 million and a median of $22.2 million in 2025 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2023 — Receivables - Net sank 99.48% — and 2025, when it jumped 7235.1%.
• Ginkgo Bioworks Holdings' Receivables - Net stood at $1.6 million in 2022, then dropped by 20.03% to $1.2 million in 2023, then sank by 57.38% to $531000.0 in 2024, then surged by 4424.67% to $24.0 million in 2025, then tumbled by 98.11% to $454000.0 in 2026.
• Business Quant data shows DNA's Receivables - Net at $454000.0 in Q1 2026, $24.0 million in Q4 2025, and $21.4 million in Q3 2025.